Literature DB >> 14989413

Prolonged untreated illness duration from prodromal onset predicts outcome in first episode psychoses.

Matcheri S Keshavan1, Gretchen Haas, Jean Miewald, Debra M Montrose, Ravinder Reddy, Nina R Schooler, John A Sweeney.   

Abstract

Several, although not all, studies suggest that prolonged duration of untreated illness (DUI) predicts poor outcome in psychotic disorders such as schizophrenia. It is unclear whether this association can be explained by factors such as baseline deficits or poor premorbid adjustment. First episode psychotic patients were evaluated at 1 and 2 years following baseline evaluations. Predictive measures showing significant correlations with outcome were entered in multiple regression analyses with Strauss-Carpenter scale (SC) and Global Assessment of Functioning scale (GAF) outcome scores as dependent variables. Illness duration computed from the onset of the prodrome (DUI-pro), used both as a dichotomous and as a continuous measure, highly significantly predicted both GAF and SC scores at 2 years. On the other hand, baseline functioning significantly predicted the 1-year but not the 2-year outcome. When Premorbid Adjustment Scale (PAS) scores were additionally entered into the analyses in a smaller subset, the relation between DUI-pro and the 2-year outcome scores remained significant. Significant associations were also seen between outcome and baseline neuropsychological deficits involving attention and memory. Further research is needed to examine whether prolonged untreated illness is simply associated with poor outcome or plays a causal role in relation to outcome. The latter, if true, would strongly support therapeutic intervention efforts in the prodromal and early psychotic phases of schizophrenia.

Entities:  

Mesh:

Year:  2003        PMID: 14989413     DOI: 10.1093/oxfordjournals.schbul.a007045

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  40 in total

1.  Visual Cortical Alterations and their Association with Negative Symptoms in Antipsychotic-Naïve First Episode Psychosis.

Authors:  Iniya Adhan; Paulo Lizano; Deepthi Bannai; Olivia Lutz; Kiranpreet Dhaliwal; Victor Zeng; Jean Miewald; Debra Montrose; Matcheri Keshavan
Journal:  Psychiatry Res       Date:  2020-04-16       Impact factor: 3.222

2.  Pre-illness cannabis use and the early course of nonaffective psychotic disorders: associations with premorbid functioning, the prodrome, and mode of onset of psychosis.

Authors:  Michael T Compton; Beth Broussard; Claire E Ramsay; Tarianna Stewart
Journal:  Schizophr Res       Date:  2010-10-30       Impact factor: 4.939

Review 3.  [Early recognition and intervention for schizophrenia].

Authors:  N Mossaheb; G Wiesegger; G P Amminger; S Kasper; J Tauscher
Journal:  Nervenarzt       Date:  2006-01       Impact factor: 1.214

4.  Prediction of community outcome in schizophrenia 1 year after discharge from inpatient treatment.

Authors:  Andreas Wittorf; Georg Wiedemann; Gerhard Buchkremer; Stefan Klingberg
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-11-07       Impact factor: 5.270

5.  Predictors of psychosis remission in psychotic disorders that co-occur with substance use.

Authors:  Carol L M Caton; Deborah S Hasin; Patrick E Shrout; Robert E Drake; Boanerges Dominguez; Sharon Samet; Bella Schanzer
Journal:  Schizophr Bull       Date:  2006-07-27       Impact factor: 9.306

6.  Untreated illness and recovery in clients of an early psychosis intervention program: a 10-year prospective cohort study.

Authors:  Gina Bhullar; Ross M G Norman; Neil Klar; Kelly K Anderson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-11-29       Impact factor: 4.328

7.  Sleep correlates of cognition in early course psychotic disorders.

Authors:  Matcheri S Keshavan; Debra M Montrose; Jean M Miewald; Ripu D Jindal
Journal:  Schizophr Res       Date:  2011-07-02       Impact factor: 4.939

8.  Symptom dimensions and functional impairment in early psychosis: more to the story than just negative symptoms.

Authors:  Daniel Fulford; Tara A Niendam; Erin G Floyd; Cameron S Carter; Daniel H Mathalon; Sophia Vinogradov; Barbara K Stuart; Rachel L Loewy
Journal:  Schizophr Res       Date:  2013-04-12       Impact factor: 4.939

9.  Duration of unspecific prodromal and clinical high risk states, and early help-seeking in first-admission psychosis patients.

Authors:  Frauke Schultze-Lutter; Jonas Rahman; Stephan Ruhrmann; Chantal Michel; Benno G Schimmelmann; Wolfgang Maier; Joachim Klosterkötter
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-07-09       Impact factor: 4.328

10.  Reduced N-acetyl-aspartate levels in schizophrenia patients with a younger onset age: a single-voxel 1H spectroscopy study.

Authors:  Jeffrey A Stanley; Madhuri Vemulapalli; Jeffrey Nutche; Debra M Montrose; John A Sweeney; Jay W Pettegrew; Frank P MacMaster; Matcheri S Keshavan
Journal:  Schizophr Res       Date:  2007-05-10       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.